Previous Close | 0.0010 |
Open | 0.0011 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0009 - 0.0011 |
52 Week Range | 0.0005 - 0.0038 |
Volume | |
Avg. Volume | 31,509,525 |
Market Cap | 56.528M |
Beta (5Y Monthly) | 0.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings Date | Jun 27, 2022 - Jun 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for BIEL
FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain. "PRIM Group in Spain serves as a perfect call point fit to provide a successful distribution of RecoveryRx in an important market in
FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico. It is expected that they will receive their initial stocking order during the 2nd
FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES UPDATE: BioElectronics Corporation is pleased to announce that it has signed two additional international distribution partners and received a new order from its longtime distribution partner in Banglade